Menu
GeneBe

1-22740019-T-C

Variant summary

Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_ModerateBA1

The NM_017449.5(EPHB2):c.61+28976T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.482 in 151,808 control chromosomes in the GnomAD database, including 19,033 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.48 ( 19033 hom., cov: 33)

Consequence

EPHB2
NM_017449.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.75
Variant links:
Genes affected
EPHB2 (HGNC:3393): (EPH receptor B2) This gene encodes a member of the Eph receptor family of receptor tyrosine kinase transmembrane glycoproteins. These receptors are composed of an N-terminal glycosylated ligand-binding domain, a transmembrane region and an intracellular kinase domain. They bind ligands called ephrins and are involved in diverse cellular processes including motility, division, and differentiation. A distinguishing characteristic of Eph-ephrin signaling is that both receptors and ligands are competent to transduce a signaling cascade, resulting in bidirectional signaling. This protein belongs to a subgroup of the Eph receptors called EphB. Proteins of this subgroup are distinguished from other members of the family by sequence homology and preferential binding affinity for membrane-bound ephrin-B ligands. Allelic variants are associated with prostate and brain cancer susceptibility. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.916 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
EPHB2NM_017449.5 linkuse as main transcriptc.61+28976T>C intron_variant ENST00000374630.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
EPHB2ENST00000374630.8 linkuse as main transcriptc.61+28976T>C intron_variant 1 NM_017449.5 P4P29323-2
EPHB2ENST00000374632.7 linkuse as main transcriptc.61+28976T>C intron_variant 1 A1P29323-3
EPHB2ENST00000400191.7 linkuse as main transcriptc.61+28976T>C intron_variant 1 P29323-1
EPHB2ENST00000544305.5 linkuse as main transcriptc.61+28976T>C intron_variant 1

Frequencies

GnomAD3 genomes
AF:
0.482
AC:
73169
AN:
151690
Hom.:
19002
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.321
Gnomad AMI
AF:
0.721
Gnomad AMR
AF:
0.572
Gnomad ASJ
AF:
0.444
Gnomad EAS
AF:
0.938
Gnomad SAS
AF:
0.718
Gnomad FIN
AF:
0.546
Gnomad MID
AF:
0.446
Gnomad NFE
AF:
0.498
Gnomad OTH
AF:
0.483
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.482
AC:
73247
AN:
151808
Hom.:
19033
Cov.:
33
AF XY:
0.495
AC XY:
36669
AN XY:
74150
show subpopulations
Gnomad4 AFR
AF:
0.322
Gnomad4 AMR
AF:
0.573
Gnomad4 ASJ
AF:
0.444
Gnomad4 EAS
AF:
0.938
Gnomad4 SAS
AF:
0.718
Gnomad4 FIN
AF:
0.546
Gnomad4 NFE
AF:
0.498
Gnomad4 OTH
AF:
0.489
Alfa
AF:
0.483
Hom.:
2971
Bravo
AF:
0.476
Asia WGS
AF:
0.778
AC:
2704
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.36
Cadd
Benign
19
Dann
Benign
0.83

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1318720; hg19: chr1-23066512; API